Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Tests Detect and Differentiate Between Common Malarias

By LabMedica International staff writers
Posted on 08 Jul 2009
Two new rapid tests offer a rapid diagnostic solution for in vitro detection of malarial antigens in whole blood.

The rapid test range is suitable for the harsh conditions of malaria endemic regions and enables highly targeted, controlled treatment through early identification. More...
Both tests detect antigens from capillary or venous whole blood and provide easy to interpret results in 15 minutes.

Introduced by Inverness Medical (Bedford, UK), the Clearview malaria tests are simple and easy to use. Clearview malaria P.f. is a qualitative test for detecting the most common, virulent, and deadly malaria-causing parasite, Plasmodium falciparum; Clearview malaria Combo detects and differentiates between P. falciparum, P. vivax, P. malariae, and P. ovale antigens.

Malaria is a parasitic disease spread by the female Anopheles mosquito, and causes severe flu-like symptoms. Each year there are an estimated 1-2 million deaths attributed to malaria. Morbidity, mortality, and transmission will be greatly reduced if the infection is accurately diagnosed and effectively treated.

The Clearview diagnostic tests are important in the Roll Back Malaria Partnership's Global Malaria Action Plan, enabling the rapid spread of antimalarial drug resistance to be minimized, as treatment can be highly targeted and controlled.

Related Links:
Inverness Medical
Malaria rapid diagnostic test information



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.